11 December 2019 - Since 2014, the Dental and Pharmaceutical Benefits Agency, TLV, has conducted an annual international price comparison report on the prices of medicines.
- This year we see that Sweden's drug prices continue to be low compared to other European countries, says Gunilla Rönnholm, Deputy Head of Unit at TLV.
Prices of medicines without competition have fallen compared with other countries and the main explanation for this is that the Swedish krona has weakened. For drugs with competition, prices have risen despite a weak krona. However, these prices remain among the lowest in Europe.